ASR Nederland N.V. (a.s.r.) is the second-largest insurer in the Netherlands. a.s.r. helps its customers share risks and build up capital for the future. a.s.r. does this with services and products that are good for today, tomorrow and always, in the fields of insurance, pensions, banking and mortgages for customers, businesses and employers. a.s.r. is also active as an asset manager for third parties.

a.s.r. is listed on Euronext Amsterdam and is included in the AEX index. a.s.r. has a total of 7,994 internal FTE’s (2022: 4,313).

a.s.r. is a public limited company under Dutch law having its registered office located at Archimedeslaan 10, 3584 BA in Utrecht, the Netherlands. Country of incorporation is the Netherlands. a.s.r. has chosen the Netherlands as ‘country of origin’ (land van herkomst) for the issued share capital and some corporate bonds which are listed on Euronext Amsterdam and Euronext Dublin (Ticker: ASRNL).

a.s.r. is registered under number 30070695 in the register of the Chamber of Commerce.

The consolidated financial statements are presented in euros (€), being the functional currency of a.s.r. and all its group entities. All amounts quoted in these financial statements are in euros and rounded to the nearest million, unless otherwise indicated. Calculations are made using unrounded figures. As a result rounding differences can occur.

The consolidated financial statements were significantly impacted by the adoption of IFRS 17 Insurance contracts and IFRS 9 Financial instruments accounting standards. The impact of these changes on a.s.r.'s profit before tax and shareholders return is disclosed in chapter 7.3.1.

In addition, the consolidated financial statements were impacted by the business combination of a.s.r. and Aegon Nederland N.V. (Aegon NL), see chapter 7.4.5.

These statements have been prepared on a going concern basis.

The financial statements for 2023 were authorised for issue by the Executive Board (EB) and approved by the Supervisory Board (SB) on 2 April 2024. The financial statements 2023 will be presented to the Annual General Meeting (AGM) of Shareholders for adoption on 29 May 2024.